Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
All Stories

Technology

1337 articles · sorted by newest first

AllAI & SocietyBig Tech & MarketsScience & SpaceCyber & Privacy

Latest in Technology

Latest in Technology
20 results
Technology 6/6/2026

SpaceX and Other Mega IPOs May Wait Years to Join the S&P 500 - Yahoo Finance

SpaceX, the aerospace titan, faces a prolonged wait before it can join the prestigious S&P 500, even after its eventual, highly anticipated Initial Public Offering. Analysts and market insiders suggest the company's aggressive investment strategy into projects like Starship and Starlink, while driving future growth, will likely delay the "four consecutive quarters of positive GAAP earnings" required for index eligibility for years post-IPO. This presents a significant hurdle for institutional investors tied to index funds eager to add the high-growth innovator to their portfolios.

Editorial Team1 min
SpaceX and Other Mega IPOs May Wait Years to Join the S&P 500 - Yahoo Finance
Technology 6/6/2026

Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on ALYFTREK at European Cystic Fibrosis Conference

Vertex Pharmaceuticals just unveiled compelling Phase 3 data for its investigational triple combination therapy, ALYFTREK, at the recent European Cystic Fibrosis Conference, demonstrating significant therapeutic impact in children aged 2 to 5. The trial showed that 65% of young patients with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes, including common F/F and F/MF mutations, achieved sweat chloride levels below the diagnostic threshold for cystic fibrosis, a critical biomarker for restored CFTR function.

Editorial Team1 min
Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on ALYFTREK at European Cystic Fibrosis Conference
Technology 6/6/2026

FIFA World Cup 2026 hype kicks off fraud, fake apps, and ransomware targeting fans and businesses

As the world gears up for the 2026 FIFA World Cup across North America, a more insidious game is already well underway: cybercrime groups are actively deploying sophisticated fraud campaigns, ransomware infrastructure, and fake mobile applications designed to exploit the global football frenzy. Security experts warn that these pre-event attacks are far more organized than anticipated, setting the stage for an unprecedented digital assault on millions of fans and event stakeholders.

Editorial Team1 min
FIFA World Cup 2026 hype kicks off fraud, fake apps, and ransomware targeting fans and businesses
Technology 6/6/2026

Warning to millions posting car pics online as fraudsters use AI to fake crashes – leaving you £1,000s out of pocket

A sophisticated new wave of insurance fraud is hitting UK motor insurers, as criminals leverage readily available generative AI to fabricate convincing car crash scenarios from innocent online vehicle photos, costing the industry millions and threatening consumer premiums. Allianz UK, a major player, has specifically flagged this escalating threat, noting the unprecedented challenge it poses to traditional fraud detection mechanisms capable of differentiating genuine damage from digitally altered images.

Editorial Team1 min
Warning to millions posting car pics online as fraudsters use AI to fake crashes – leaving you £1,000s out of pocket
Technology 6/5/2026

AI Enhances Global Radiotherapy Data Collection - Mirage News

A new Artificial Intelligence (AI) platform, OncoAI DataLink, has launched globally, spearheaded by the Global Radiotherapy Alliance and backed by the World Health Organization (WHO). This groundbreaking tool is set to revolutionize the collection and standardization of radiotherapy data for cervical cancer, promising to accelerate research and refine treatment protocols, especially in regions where data has been historically fragmented.

Editorial Team1 min
AI Enhances Global Radiotherapy Data Collection - Mirage News
Technology 6/5/2026

Australia's AirTrunk to invest $30 billion in India by 2030

Australian data center giant AirTrunk, backed by global investment titans Blackstone and CPPIB, has committed a staggering $30 billion to expand its footprint in India by 2030. This monumental investment signals a fresh escalation in the race to capture India's burgeoning digital economy, transforming the nation into a global hub for critical data infrastructure following AirTrunk's strategic entry in April via Lumina CloudInfra.

Editorial Team1 min
Australia's AirTrunk to invest $30 billion in India by 2030
Technology 6/5/2026

Researchers test accuracy of simulation tools for floating PV

A groundbreaking study from the Indian Institute of Technology Madras (IITM) has delivered critical insights into the reliability of key simulation tools for floating photovoltaic (FPV) projects, finding significant discrepancies between predicted and actual performance. Their two-year evaluation, concluded last month, revealed that while PVsyst showed the highest accuracy for energy yield, PVSOL consistently overestimated output, raising red flags for project developers banking on these models for investment decisions.

Editorial Team1 min
Researchers test accuracy of simulation tools for floating PV
Technology 6/5/2026

Anthropic engineers helping US deploy Mythos AI for cyber operations

The United States National Security Agency (NSA) is reportedly leveraging Anthropic's advanced artificial intelligence model, Mythos AI, to strategize and execute global cyber operations, a development first reported by the Financial Times. This collaboration marks a significant escalation in the integration of frontier AI into offensive and defensive national security infrastructure, raising immediate questions about algorithmic transparency and control in critical cyber warfare domains.

Editorial Team1 min
Anthropic engineers helping US deploy Mythos AI for cyber operations
Technology 6/5/2026

Supreme Court sides with Trump administration on federal regulation of telecom companies

In a decisive 6-3 ruling, the Supreme Court today upheld the Federal Communications Commission's authority to impose multi-million dollar penalties on major telecom companies, specifically siding with an interpretation of the Communications Act favored by the Trump administration. The decision rejects challenges from industry giants Verizon and AT&T, who argued the FCC overstepped its bounds in enforcing specific service and disclosure requirements during a period of significant regulatory flux.

Editorial Team1 min
Supreme Court sides with Trump administration on federal regulation of telecom companies
Technology 6/5/2026

US House lawmakers release draft bill to prohibit state AI rules

In a significant move poised to reshape the future of artificial intelligence governance in the United States, a bipartisan duo from the US House of Representatives, Reps. Ted Lieu (D-CA) and Ken Buck (R-CO), yesterday unveiled draft legislation aimed at precluding states from enacting their own AI development regulations. Dubbed the "AI Model Accountability and Preemption Act," this bill seeks to establish a unified federal framework, a proposition vigorously championed by leading tech firms eager to avoid a complex regulatory patchwork.

Editorial Team1 min
US House lawmakers release draft bill to prohibit state AI rules
Technology 6/5/2026

Journal retracts study linking hepatitis vaccine to autism that was included in CDC review - Retraction Watch

The scientific community is grappling with a significant blow to public health misinformation efforts as the Journal of Immunological Research formally retracted the controversial "Smith et al." paper, which baselessly posited a link between the Hepatitis B vaccine and autism spectrum disorder. This decisive move by the journal comes after years of intense scrutiny regarding the study's methodological integrity and undisclosed conflicts of interest, dealing a fresh setback to vaccine skepticism. The retraction is particularly impactful given the paper's brief, albeit highly scrutinized, inclusion in a broader data review by the Centers for Disease Control and Prevention (CDC) in 2020.

Editorial Team1 min
Journal retracts study linking hepatitis vaccine to autism that was included in CDC review - Retraction Watch
Technology 6/5/2026

Canada’s new AI plan commits billions for AI adoption, new jobs and skills training

Ottawa has greenlit a sweeping C$2.8 billion package over five years, spearheaded by Innovation, Science and Economic Development Canada (ISED), to catapult Canada's AI sector while simultaneously fortifying digital safeguards. The ambitious plan targets accelerated AI Adoption across industries, aggressive Skills Training for a future-ready workforce, and robust frameworks for AI Governance and online safety. This move positions Canada to capitalize on its research strengths while addressing the societal implications of rapidly advancing Generative AI.

Editorial Team1 min
Canada’s new AI plan commits billions for AI adoption, new jobs and skills training
Technology 6/4/2026

DigMethpy: An AI-Driven Platform for Accelerating Methane Pyrolysis Catalyst Discovery

A groundbreaking AI platform, DigMethpy, has been unveiled by a research consortium including the Global Energy Materials Institute (GEMI) and Synapse AI Labs, poised to radically accelerate the discovery of catalysts for methane pyrolysis. Published in a recent issue of Nature Catalysis, the system leverages sophisticated machine learning and quantum chemistry simulations to design and screen novel catalyst materials with unprecedented speed, potentially unlocking cost-effective, emissions-free hydrogen production within years, not decades.

Editorial Team1 min
DigMethpy: An AI-Driven Platform for Accelerating Methane Pyrolysis Catalyst Discovery
Technology 6/4/2026

Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics

Alamar Biosciences has launched its NULISA DBS Extraction Kit, a significant advancement making ultra-high-sensitivity, multiplex proteomics feasible from home-collected fingerstick samples. This innovation directly addresses long-standing logistical hurdles, unlocking new possibilities for longitudinal, decentralized, and population-scale research essential for the earliest detection of diseases like Alzheimer's and inflammatory conditions.

Editorial Team1 min
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics
Technology 6/4/2026

Reply and IEO Launch Collaboration to Co-Develop and Train Domain-Specific Large Language Models for Oncology

In a strategic move set to accelerate the application of generative AI in critical medical fields, Reply, the Italian tech consultancy, and the prestigious European Institute of Oncology (IEO) have formally initiated a collaboration to co-develop and train advanced, domain-specific Large Language Models tailored for oncology. This partnership aims to unlock new frontiers in cancer research and patient care by leveraging IEO's vast clinical data and Reply's deep AI expertise.

Editorial Team1 min
Reply and IEO Launch Collaboration to Co-Develop and Train Domain-Specific Large Language Models for Oncology
Technology 6/4/2026

Minimally Invasive Solution For TMJ Disorders - CodeBlue

The CodeBlue System, a novel minimally invasive solution for Temporomandibular Joint (TMJ) Disorders, is rapidly gaining traction across specialist clinics, particularly in key U.S. markets like University Park, TX, as practitioners tout its efficacy in drastically reducing chronic orofacial pain with significantly shorter recovery times. This breakthrough, driven by advancements in precision diagnostics and targeted intervention, addresses a debilitating condition often plagued by diagnostic oversights and inadequate treatment pathways.

Editorial Team1 min
Minimally Invasive Solution For TMJ Disorders - CodeBlue
Technology 6/4/2026

Instagram Begins Warning Users Affected by Meta AI Hack That Enabled Account Takeovers

Instagram has begun issuing stark warnings to users caught in a recent wave of account takeovers, directly attributing the compromise to a sophisticated vulnerability within Meta AI's integration. The Menlo Park-based tech giant's AI chatbot, designed to enhance user experience, was instead exploited by attackers to gain unauthorized access, sparking fresh alarms across the platform's vast user base over the last week.

Editorial Team1 min
Instagram Begins Warning Users Affected by Meta AI Hack That Enabled Account Takeovers
Technology 6/4/2026

Use of ultra-fast acting insulin With smart insulin pump system Improves Glucose Control in Type 1 Diabetes: Study

A new landmark study confirms that combining Eli Lilly's ultra-fast acting insulin Lyumjev with the Medtronic MiniMed 780G smart insulin pump system dramatically improves glucose control for both children and adults with Type 1 Diabetes. The findings, presented this week at the American Diabetes Association's annual conference, mark a significant leap towards more autonomous diabetes management, demonstrating superior time-in-range metrics and reduced hypoglycemia without increased burden.

Editorial Team1 min
Use of ultra-fast acting insulin With smart insulin pump system Improves Glucose Control in Type 1 Diabetes: Study
Technology 6/4/2026

New Technologies Expand Treatment Options for Calcified Coronary Lesions: Study

Groundbreaking data unveiled at EuroPCR 2026 has confirmed a paradigm shift in treating severely calcified coronary lesions, long considered a formidable barrier to effective revascularization. Experts highlighted how the strategic combination of advanced atherectomy techniques—Rotational Atherectomy (RA) and Orbital Atherectomy (OA)—with Intravascular Lithotripsy (IVL) is now routinely overcoming these challenges, offering viable Percutaneous Coronary Intervention (PCI) options for patients previously relegated to complex bypass surgery or palliative care.

Editorial Team1 min
New Technologies Expand Treatment Options for Calcified Coronary Lesions: Study
Technology 6/4/2026

ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows

New findings from the landmark FLOW trial, unveiled today at the 63rd ERA Congress in Glasgow, confirm that once-weekly semaglutide significantly improves health-related quality of life (HRQoL) for patients battling both type 2 diabetes and chronic kidney disease (CKD). This pivotal data goes beyond previously reported reductions in kidney disease progression, underscoring semaglutide's profound impact on patients' daily lives and well-being, not just clinical metrics.

Editorial Team1 min
ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows
‹ Prev1…5455565758…67Next ›

Page 56 of 67 · 1337 articles

ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies